Event countdown

Choose: Select your preferred online session during registration (late February to early March 2025) - register today

Time: 7:30-8:30pm (AEDT) - see timezones

Location: Virtual, via the Praxhub platform. Access details will be confirmed upon registration. Attendees must use a laptop/PC with webcam and reliable internet to join the meetings.

Session Details

Merck Healthcare is pleased to offer this unique educational program for neurologists around Australia. Neurologists are invited to attend a single, virtual small-group discussion facilitated by a leading MS expert. Groups will be limited to no more than 10 attendees, allocated on a first-in first-served basis.

In this collaborative peer discussion, you'll:

• Deepen your understanding: Gain practical insights into optimising Mavenclad® treatment strategies.
• Explore complex cases: Analyse real-world scenarios and discuss best practices with leading MS experts.
• Share and learn: Engage in open discussions with peers and address those lingering questions you might have.
• Expand your network: Connect with fellow neurologists who share your passion for improving MS care.

About this education

Describe key determinants for selecting switch therapies in MS patients.

5

Demonstrate a framework for assessing menopausal symptom severity and for providing advice to women on options for optimal management.

1

Recall the clinical features,benefits and risks of Mavenclad® (cladribine) in MS treatment.

3

2

Identify optimal treatment options for new MS patients when considering symptoms, disease progression and patient characteristics.

4

Learning Outcomes

1. Introductions
2. Presentation: Optimising MS Treatment Strategies: A Rediscover of Mavenclad in Clinical Practice – 10 mins 
3. Case Study Presentations – 30 mins 
4. Discussion – 20 mins 

Agenda

This education has been developed with a panel of leading experts. Each session will be led by one of the following:

Neurologist at St Vincent's Hospital, researcher in MS & neuroimmunology

Dr Jennifer Massey

Neurologist Eastern Health

Dr Katherine Buzzard

Neurologist at Alfred Health Neuroscientist at Monash Dept of Neuroscience.

Dr Mastura Monif

Neurologist & Neuroimmunologist, North Shore Private Hospital, CEO of CU Health

Dr Patrick Aouad

Education Steering Committee / Presenters

Dr Mastura Monif

Education Steering Committee

This was an excellent outline of dyslipidaemia management by both presenters. The best on the subject that I have been to in the last 2 years. Clear, concise and useful.

This education is sponsored Merck Healthcare. All content is the true, accurate and independent opinion of the authors/presenters and the views expressed are entirely their own.

To access hundreds of quality CPD training courses, simply join Praxhub's online medical community